Turn Under-Recognized Research Into Licensing-Ready Opportunities
SynapseMed helps Technology Transfer Offices proactively mine disparate institutional research output, cluster it into commercial opportunity areas, and generate buyer-ready narratives for licensing conversations.
SynapseMed opportunity engine
1. Ingest SignalsPublications
Patents
Clinical trials
Institutional technology listings
Patents
Clinical trials
Institutional technology listings
→
2. Cluster OpportunitiesGroup related science into opportunity areas and translational themes
→
3. Generate BriefsCommercial thesis
Market context
Regulatory
Reimbursement path
Likely buyers
Market context
Regulatory
Reimbursement path
Likely buyers
Ranked opportunity queue
Top 10 shortlist
Commercializations
Buyer-ready narratives
Discover the Right Signal!
Most research institutions already have the raw material for valuable commercialization. The challenge is finding the patterns early enough, framing them clearly enough, and connecting them to buyers who care.
Too much science, not enough triage
Strong research output can outpace the capacity of TTO teams to evaluate every signal commercially.
Disclosures are reactive
Waiting for inventor disclosures means commercially relevant patterns may be missed or discovered late.
Industry buyers need a thesis
Buyers do not just need a patent number. They need a clear problem, market rationale, pathway, and fit.
Where the Traditional Model Leaves Gaps
Traditional technology transfer flow
Research OutputPublications, grants, abstracts, posters, lab discoveries
DisclosureInventor-initiated invention disclosure when timing and awareness align
IP ManagementPatentability review, filing decisions, portfolio triage
LicensingOutbound marketing, industry interest, option/license negotiation
The model works, but it is often reactive. Valuable opportunities can remain invisible when they are not disclosed early, not framed commercially, or not connected to the right market signal.
A Proactive Discovery Layer for TTOs
Instead of waiting for disclosures alone, SynapseMed scans the scientific and IP footprint around an institution and turns scattered evidence into a prioritized commercialization queue.
What Your TTO Receives
Opportunity Queue
A ranked list of technology themes surfaced from institutional output.
Commercial Briefs
Concise, buyer-facing narratives with market, regulatory, reimbursement, and competitive context.
Partner Map
Likely strategic buyers, licensing partners, and companies already active in the opportunity area.
Pilot Structure
A focused pilot gives your office a practical view of what is hiding inside existing research output.
- One institution or defined research area
- Publications, patents, trials, and available technology listings
- Ranked opportunity queue
- Top 3 opportunity briefs ready for internal review
Week 1Institution signal collection and normalization
Week 2Opportunity clustering and evidence queue generation
Week 3Top opportunity briefs with market and buyer context
Final reviewDecision meeting with TTO stakeholders
Example Use Case: Academic Medical Center / University Portfolio
For a university-style portfolio, the system can scan technology listings for your, and your other associated institutes, PubMed-linked publications, patent records, and clinical trial signals, then identify the opportunity areas most likely to support licensing or strategic partnering discussions.
Inputs
Technology listings, publications, patents, trials
Analysis
Signal clustering, commercial framing, pathway assessment
Output
Top opportunities with likely buyers and next-step recommendations
Start With One Pilot
Would you like to use one clean pilot to see whether SynapseMed can uncover commercially useful opportunities your office may not otherwise prioritize?
Request a sample report or schedule a 30-minute review.
Contact SynapseMed
Replace this block with your preferred form shortcode.
Common TTO Questions
No. It is designed to sit upstream of your current workflow and surface opportunities your team can review, validate, and act on.
No for the initial pilot. The first pass can use public and institution-linked signals: publications, patents, trials, and available technology listings.
A ranked opportunity queue, a top-10 shortlist, and top 3 commercialization briefs with market context, pathway notes, and likely buyers.
Universities, academic medical centers, and research institutes with strong output but limited bandwidth for proactive commercial scanning.
Yes. This is exactly the idea – to keep track of all the innovations at your institute without you lifting a finger!